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Abstract
Background: Depressive and anxiety disorders are highly prevalent, but only a small percentage (approximately
50%) of patients receive appropriate treatment. Relevant barriers include communication and coordination gaps
between different providers that result from the lack of integration between different care-giving systems. Aftercare
following inpatient treatment represents one of these gaps because systematic follow-up care does not exist. Case
management-based aftercare coordination by phone might be a promising approach to overcoming this gap and
improving long-term treatment outcomes. Case management is a patient-centered and situation-based approach
comprising systematic tracking and support of patients by a case manager.
The aim of this study is to evaluate the effectiveness of aftercare coordination by phone for patients with
depressive and anxiety disorders.
Methods/design: The effectiveness of aftercare coordination will be investigated in a prospective randomized
controlled trial in four psychotherapeutic inpatient routine care units (St. Franziska-Stift Bad Kreuznach, MediClin
Seepark Klinik Bad Bodenteich, Segeberger Kliniken Gruppe Bad Segeberg and Luisenklinik Bad Dürrheim). The
patients receiving aftercare coordination (intervention group; IG) will be compared with those who receive treatment
as usual (TAU control group; CG). Eligible patients will be required to have a diagnosis of an anxiety and/or depressive
disorder and a recommendation for follow-up outpatient psychotherapy.
The aftercare coordination consists of six phone contacts at intervals of two weeks that are performed by therapists in
the inpatient units. The patients will complete questionnaires at discharge (t1), 3 months after discharge (i.e., at the end
of the intervention (t2)) and 9 months after discharge (t3). The primary outcome will be change in symptom severity
from t1 to t3, the secondary outcomes will be health-related quality of life and the proportion of patients who manage
to begin outpatient psychotherapy by t3.
Discussion: This study will determine whether case management-based aftercare coordination by phone is an adequate
approach for overcoming treatment barriers in the clinical pathways of patients with depressive and anxiety disorders. If
proven effective, an accessible supplementary treatment approach that will help to maintain and even improve
long-term treatment outcomes will be made available for patients following inpatient treatment.
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Background
Depressive and anxiety disorders are among the most
prevalent mental disorders and cause significant per-
sonal, social and economic burdens. Despite the high
12-month prevalence rates of 15.3% for anxiety and 7.7%
for depression in Germany [1] only approximately half
of these patients receive appropriate treatment [2]. This
finding is indicative of undertreatment and the need for
the optimization in the care of patients with anxiety and
depression. Significant barriers in the patients’ pathways
include communication and coordination problems be-
tween different services or providers [3-6]. The aftercare
following inpatient treatment represents one of these
gaps. After inpatient treatment, follow-up outpatient
psychotherapy is clinically indicated for the majority of
patients with anxiety and depressive disorders [7]. Here,
the aims are to consolidate the treatment outcomes and
to minimize the so-called rebound-effect, i.e., the long-
term reduction in positive treatment effects following in-
patient treatment. Although there is evidence supporting
the effectiveness of inpatient treatment, treatment effects
often decrease after treatment. A portion of patients
who exhibit improvements at termination relapse and
continue to seek help from a variety of mental health
providers [8]. Depressive disorders are particularly highly
recurrent, and the risk of a further episode increases
with each additional episode; thus, the prevention of re-
lapse is extremely desirable [9]. It can be assumed that
the therapeutic alliance represents a protective factor
against rebound effect; numerous studies have found
that the therapeutic alliance is relevant to the outcome
of psychotherapy [10] and the prevention of relapse [11].
However, the high risk of relapse indicates that follow-
up support, e.g., outpatient psychotherapy, is necessary
for patients to maintain long-term treatment outcomes
after returning to everyday life. In addition to outpatient
psychotherapy and primary and specialist care, patients
can also profit from low-intensity offerings such as self-
help groups and counseling. Thus, several aftercare
treatment options exist, but many patients do not access
follow-up treatment. Treatment barriers that result from
a lack of integration of the different steps in care can
occur on the systemic level (e.g., long waiting times for
outpatient psychotherapy) and on the individual level (e.g.,
insufficient patient awareness of available treatments) [6].
Case management-based aftercare coordination by
phone might be a promising approach to overcoming
the gap between inpatient treatment and aftercare. Case
management is a patient-centered and situation-based
approach comprised of systematic tracking and support
of patients by a case manager. The primary goal is to
coordinate and integrate services across treatment set-
tings by providing self-managing support and follow-up
for patients [3].
Previous international research on the effectiveness of
case management has consistently reported positive effects
on treatment outcomes, e.g., symptoms, quality of life and
patient satisfaction [12-14]. However, in Germany, case
management programs for anxiety and depression have
not yet been implemented. Because the German health-
care system differs significantly from the systems of other
countries, the transferability of results from international
studies still requires to be verified [14]. Furthermore, the
various case management-based approaches differ con-
cerning their content and the health care setting in which
they are implemented. The first effectiveness study of a
case management model for patients with depression in
the German health care system reported that phone-based
case management in primary health care results in better
treatment outcomes compared to regular care in terms of
symptom reduction, medication adherence and patient
satisfaction [15]. Here, the intervention focused on moni-
toring depression symptoms, adherence to medication and
encouraging the patients to follow self-managing activities
and engage in pleasant or social activities. In this study,
the focus of the intervention will be on the coordination
of an adequate aftercare for patients with anxiety and de-
pressive disorders.
Objectives
This study aims first to evaluate the effectiveness of
aftercare coordination by phone following inpatient
treatment for patients with anxiety and depression. The
primary outcome will be change in symptom severity
from t1 to t3, and the secondary outcomes will be health-
related quality of life, self-efficacy and the proportion of
patients who managed to begin outpatient psychotherapy
at follow-up (6 months after the intervention). Whether
the patients who receive the aftercare coordination (i.e.,
the intervention group; IG) exhibit better treatment
outcomes at the terminations of the intervention and
follow-up compared to the patients who receive treat-
ment as usual (TAU, i.e., the control group; CG) will be
examined. Second, whether patient characteristics can
predict the outcomes of aftercare coordination will be
examined. Third, whether the therapeutic alliance dur-
ing inpatient treatment has moderating effects on the
primary and secondary outcomes will be examined.
Forth, different anxiety-specific measures will be assessed
to determine the changes in the symptom severities in
patients with different anxiety disorders. Fifth, process
evaluation will be conducted to identify the main contents
of the aftercare coordination and to determine whether
the patients benefit during the course of the intervention
from the perspective of the therapists. Finally, the patients’
satisfaction with the case management procedures and
acceptance of the intervention will also be assessed.
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Ethical approval
The study has been approved by the responsible local
Ethics Committee of the Chamber of Physicians in
Hamburg (Ref. Nr. PV4004) and will be conducted ac-
cording to the principles of the Declaration of Helsinki
(2013 version).
Methods/design
Study design
The study will be performed as prospective multicenter
randomized controlled trial (Figure 1). The patients who
receive aftercare coordination by phone (IG) will be com-
pared to those who receive TAU without aftercare coord-
ination by phone (CG). Measurements will be performed
at three time points in each group. Baseline measures will
be taken at discharge from the inpatient treatment (which
will be the beginning of the intervention; t1), and two
follow-up measures will be taken after 3 months at the
end of the intervention (t2) and again 6 months after the
end of the intervention (which will be 9 months after dis-
charge from inpatient treatment; t3).
Trial inclusion and exclusion criteria
The included patients will be required to be at least
18 years old and have a diagnosis of anxiety (F40.x,
F41.x, according to ICD-10) [16] and/or depressive dis-
order (F32.x, F33.x, F34.1). The diagnoses will be vali-
dated with the Mini-DIPS diagnostic interview [17],
which is a short version of the DIPS diagnostic interview
for mental disorders [18]. Comorbid mental disorders or
somatic comorbidity will not be an exclusion criterion.
Patients who are already in a concurrent outpatient
psychotherapeutic treatment at admission that will be
continued after the inpatient treatment will be excluded
from the study because aftercare coordination will not
be necessary for those patients. Further exclusion criteria
include acute risk of suicide, acute psychosis or psychotic
symptoms, insufficient German language skills and an
inpatient treatment duration of less than three days.
Recruitment and data collection
The patients who fulfill the study inclusion criteria will
be recruited consecutively by their therapists at the be-
ginning of their inpatient treatment in the four cooper-
ating psychotherapeutic inpatient units (St. Franziska-
Stift Bad Kreuznach, MediClin Seepark Klinik Bad
Bodenteich, Segeberger Kliniken Gruppe Bad Segeberg
and Luisenklinik Bad Dürrheim). Prior to participation,
the patients will be informed with oral and written in-
formation regarding the study by their therapists. After
written informed consent is obtained, the patients will
be randomly assigned to the IG or the CG.
Randomization
The patients will be randomized using a stratified block
randomization with randomly varying block size to ensure
concealment and equal group sizes, and the randomization
will be stratified by the participating clinical units. The
randomization will take place at the individual level at the
University Medical Center Hamburg-Eppendorf one week
before the beginning of the intervention. The allocation
schedule was created with a computer program (Microsoft
Excel, Windows) by a researcher at the University Medical
Center Hamburg-Eppendorf. The therapists will be in-
formed about the randomization outcome prior to the last
psychotherapeutic session during inpatient treatment so
that they can inform the patients about their group assign-
ment before discharge.
Description of the intervention and control conditions
Intervention condition
The aftercare coordination is based on the concept of
case management, which is a patient-centered approach
that aims to support the patient in finding and organizing
his or her individual aftercare treatment. After the inpatient
treatment, the patients in the intervention group will re-
ceive six aftercare coordination phone contacts at intervals
of two weeks that will be performed by their inpatient treat-
ment therapists for 12 weeks. The task of the therapists will
be to accompany and guide the patients in matters related
to making plans and generating goals. The patients should
Figure 1 Study design and expected sample sizes.
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be motivated and encouraged in terms of empowerment to
become active in organizing their own aftercare treatment,
and the therapists will provide feedback by monitoring the
steps taken toward goal achievement. During the aftercare
coordination, and in contrast to therapeutic interventions,
the treatment of the patients’ disorder-specific complaints
will not be the primarily focus. The main contents of the
phone contacts will be the patients’ needs and problems as-
sociated with their aftercare coordination and supportive
consultation from the therapist.
Prior to initiating the aftercare coordination, the ther-
apists will be trained in their role as a coordinator and
receive an elaborate manual that will provide guidelines
for the phone contacts. This detailed manual contains
helpful instructions for the therapist but allows sufficient
freedom to tailor the coordination to the patients’ needs,
individual situations and conditions. The contents of the
manual include descriptions of the aims of the aftercare
coordination, the processes of the study and the phone
contacts and instructions for dealing with specific situations
that are demonstrated via examples. The phone contacts
should last 20 to 30 minutes each. After each phone con-
tact, the therapists will complete a self-developed question-
naire that includes process documentation of the duration
and contents of the contact (see process measurements).
Control condition
After inpatient treatment, the patients in the CG will re-
ceive treatment as usual with routine care that does not
involve the aftercare coordination by phone that the pa-
tients in the intervention group will receive. The patients
in the control group will not have any contact with their
therapists from the clinic after the inpatient treatment.
Outcome assessment
Primary outcome measures
The primary outcome measure is symptom severity,
which will be assessed using Beck’s Depression Inventory
(BDI-II) [19]. The BDI-II consists of 21 items that are
rated on a four-point Likert scale and yields a total score
via the summation of the ratings for the individual items
(range: 0 to 63; higher scores indicate higher symptom
severity). The mean BDI cut-off scores for minimal,
mild, moderate and severe depressive symptoms are 7.7,
19.1, 27.4 and 33.0, respectively. The BDI-II is a reliable
and valid measure of depression symptoms with an internal
consistency ranging from .92 to .93. This instrument has
been widely used and is sensitive to change.
Secondary outcome measures
The secondary outcomes include health-related quality
of life as measured with the EuroQol-5D [20] and the
Short Form 8 Health Survey (SF8) [21]. The >EuroQol-5D
is a generic instrument that measures health-related
quality of life in five dimensions; i.e., mobility, self-care,
usual activities, pain/discomfort and anxiety/depression.
Health-related quality of life will also be assessed with a
visual analogue scale (range: 0 to 100; higher ratings in-
dicate higher quality of life). The SF-8 is a short version
of the SF-36 [22] allows for the calculation of scores for
physical and mental health (range: 0 to 100; higher scores
indicate better statuses). This instrument has good psycho-
metric properties with an internal consistency between .70
and .88 [23].
As an additional secondary outcome, the proportion of
patients who managed to organize outpatient psycho-
therapy at follow-up will be assessed with self-report
items. Whether self-efficacy can be improved by the case
management-based intervention that aims to empowering
the patients to become active will also be investigated. The
German General Self-Efficacy Scale (SWE) [24] will be used
to assess self-efficacy. This scale comprises 10 four-point
Likert-scale items that range from 1 (‘totally disagree’) to 4
(‘totally agree’). The questionnaire includes items such as
“If there are challenges, I can find a way to succeed” and “I
can find a solution for every problem”. The summed scores
range between 10 and 40, and higher scores indicate greater
general self-efficacy. The internal consistency of this instru-
ment ranges from .80 to .90 [24].
Additional measures
To investigate whether patient characteristics can pre-
dict the outcomes of aftercare coordination, the follow-
ing demographic and clinical characteristics will be
collected via a self-report questionnaire: age, gender,
marital status and partnership, children, level of educa-
tion, employment status and occupational situation,
and medical and psychosocial treatment prior to the in-
patient treatment. To examine whether the therapeutic al-
liance is associated with the primary outcome, the
therapeutic relationship will be measured with the Helping
Alliance Questionnaire (HAQ-S) [25], which consists of
11 items that are rated on a six-point Likert scale ranging
from −3 (‘strongly disagree’) to 3 (‘strongly agree’). A total
score is calculated, and higher total scores are indicative of
better alliances. Research has demonstrated the good reli-
ability and validity of this instrument [26].
Anxiety-specific measures
Additionally, Beck’s Anxiety Inventory (BAI) [27] will be
utilized to measure the changes in anxiety symptom sever-
ity. The BAI contains 21 items that assess the degree to
which the respondent has been affected by physical or cog-
nitive symptoms of anxiety during the past week. The BAI
items are also meant to reflect panic attack symptoms. The
total score ranges from 0 to 63, and high scores indicate
more severe anxiety. The internal consistency ranges from
.83 to .95. To gather data regarding changes in the severity
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of the symptoms of specific anxiety disorders, the following
diagnosis-specific outcome measures will be used only in
the questionnaires for the patients with anxiety diagnoses.
Generalized anxiety disorder symptoms will be assessed
with the seven-item Generalized Anxiety Disorder Scale
(GAD-7) [28], which measures the symptom severity over
the previous two weeks on a four-point Likert scale that
ranges from 0 (“not at all”) to 3 (“nearly every day”).
The sum score ranges from 0 to 21. Scores of 5, 10,
and 15 represent the cut-off points for mild, moderate
and severe anxiety, respectively. This instrument is a
reliable and valid measure of anxiety with an internal
consistency of .89 [29]. Panic disorder symptoms will
be measured with the Body Sensations Questionnaire
(BSQ) and the Agoraphobic Cognitions Questionnaire
(ACQ) [30]. The BSQ contains 17 items concerning the
degree to which the patient fear somatic symptoms that
are commonly associated with anxiety and panic at-
tacks. This inventory assesses the fear of certain body
sensations. The items are rated on a five-point Likert
scale ranging from 1 = “not frightened or worried by
this sensation” to 5 = “extremely frightened by this sen-
sation”. The total score is calculated by averaging the
individual item ratings. The internal consistencies in
different samples range from .80 to .95 [31]. The ACQ
measures the frequency of fear-related cognitions, and
the fear of negative social or health consequences of
fear. The ACQ contains 14 items (6 behavioral-social
and 8 physical items) that are rated on a five-point
Likert scale ranging from 1 = “the thought never
occurs” to 5 = “the thought always occurs when I am
nervous”. The internal consistency in different samples
ranges from .74 to .87 [31]. The total score is derived
by averaging the individual item ratings.
Agoraphobic symptoms will be assessed with the
Mobility Inventory (MI) [32], which is a 26-item self-
report questionnaire that was designed to assess the sever-
ity of the avoidance of common agoraphobic situations.
Each situation is rated on a five-point Likert scale ranging
from 0 (never avoids) to 4 (always avoids). Each situation
is rated twice to reflect the degrees to which each situation
is avoided by the agoraphobic participant when he is alone
and when he is accompanied. The MI is scored by calcu-
lating the average avoidance rating across all situations for
the Avoidance Alone and Avoidance Accompanied Scales.
The internal consistency in different samples ranges from
.85 to .97 [31].
The Social Phobia Scale (SPS) and the Social Interaction
Anxiety Scale (SIAS) [33] will be used to measure social
anxiety. The SPS assesses anxiety in 20 performance situa-
tions, and the SIAS was constructed to measure anxiety in
20 social interaction situations. Each situation is rated on
a 4-point scale ranging from 0 to 4. The sum scores for
both questionnaires range from 0 to 80, and higher scores
represent greater anxiety about being observed by others
or social interactional anxiety. The cut-offs are >24 for the
SPS and >35 for the SIAS. The internal consistencies in
different German samples range from .94 to .95 for the
SPS and .86 to .88 for the SIAS [34].
Process measurements
To identify the main contents and to determine if the
patients benefit during the course of the aftercare coord-
ination from the perspective of the therapists, a process
evaluation will be conducted. After every phone contact,
the therapist will answer questions such as ‘Which steps
have been generated, and did the patient carry out these
steps?’, ‘Is the patient motivated and open to the aftercare
coordination and benefiting from it?’ and ‘What was the
central task of the therapist during the phone contact, e.g.,
motivating the patient, informing and consulting, planning
the next steps, and controlling and monitoring of the pa-
tient’s progress?’ in the developed questionnaire.
Furthermore the patients’ satisfaction with the interven-
tion procedures and acceptance of the aftercare coordin-
ation will be assessed with 25 self-generated items. For
example, the items will include “The phone contacts
helped me in finding my way back to everyday life” and
“My therapist and I always discussed the individual steps
of my aftercare support” and will be rated on a five-point
Likert scale ranging from 1 (‘totally agree’) to 5 (‘totally
disagree’). Additionally, the patients will be asked to
answer some open questions such as “What could be im-
proved regarding the aftercare coordination?”.
Statistical analyses
The primary analysis will focus on the changes in symp-
tom severity from t1 to t3 as assessed with the BDI-II.
Comparisons between the IG and the CG will be calcu-
lated with mixed model analyses of covariance (ANCO
VAs) with symptom severity as the dependent variable
and gender and initial symptom severity as covariates.
An advantage of this method is that it includes all avail-
able data even if the data from another time point for a
specific person are missing. Other secondary analyses
will be performed regarding changes in health-related
quality of life, self-efficacy and anxiety symptom severity
from t1 to t2 and from t1 to t3. Following the intention-
to-treat approach (ITT), we will analyze all randomized
participants in the primary analysis to avoid biases such
as non-random attrition of the participants. Additionally,
a sensitivity analysis following the per-protocol approach
will be conducted. This analysis will be performed in-
cluding only the participants that have completed all
measurements. To investigate whether the patient char-
acteristics (e.g., age, level of education, and psychosocial
treatment before the inpatient treatment) and patient
ratings of the therapeutic alliance predict the outcomes
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of the aftercare coordination, different regression ana-
lysis models will be applied to the primary and second-
ary outcomes. Process evaluation and data about the
patients’ satisfaction and acceptance will be investigated
via descriptive and qualitative analyses. We will also con-
duct drop-out analyses to compare the demographic and
clinical baseline characteristics of the completers and
non-completers (t- and χ2-tests). The analyses will be
conducted with SPSS 21.
Power calculation
We expect a moderate effect size, which is defined as
f = 0.25 according to Cohen [35], for the primary out-
come because recent studies that have investigated
aftercare programs have reported moderate effect sizes in
terms of changes in symptom severity (e.g., depressive-
ness) [36]. We expect a reduction of the error variance of
approximately 30% due to the inclusion of initial symptom
severity (BDI at t1) as a covariate (which can be expected
to be uncorrelated with the study conditions due to the
randomization). These considerations lead to an adjusted
effect size of f = 0.29. To detect a moderate effect between
the intervention and control groups in terms of the symp-
tom severity with a power of 80% and an α of 0.05, a sam-
ple size of N = 96 (48 per group) is required. Based on an
expected dropout rate of approximately 50% from baseline
(t1) to 9 months of follow-up (t3), we aim to include a
sample of N = 192 (96 per group) to perform the per-
protocol analysis with a sufficient sample size.
Discussion
This paper presents a study protocol for a prospective
multicenter RCT evaluating the effectiveness of case
management-based aftercare coordination by phone fol-
lowing inpatient treatment for patients with depressive
and anxiety disorders. The evaluated intervention is a
manualized aftercare approach that is delivered by spe-
cially trained therapists that focuses on supporting the
patients in finding and organizing their individual after-
care treatment. Considering the positive effects of case
management for patients with depressive and anxiety
disorders in terms of symptom reduction and quality of
life that have been reported in previous studies in other
settings [12,13,15,14], we hypothesize that aftercare co-
ordination following inpatient treatment will help to
minimize the risk of relapse and consolidate and even
improve long-term treatment outcomes. To the extent
of our knowledge, the present RCT will be the first to
examine the effects of case management-based aftercare
coordination by phone for patients with depressive and
anxiety disorder. Acquiring access to adequate follow-up
treatment should help the patients to maintain positive
treatment outcomes after returning to everyday life. Al-
though initiating outpatient treatment is the decisive aim of
the intervention, it is not the primary or only criterion of
success. Depending on the structural circumstances in the
health care system, there might be situations in which it is
not possible to initiate an adequate aftercare treatment, e.g.,
in cases of long waiting times for outpatient psychotherapy
[37], within the three month of the intervention. However,
there are several potential aftercare treatment possibilities
other than outpatient psychotherapy and primary and spe-
cialist care, including low-threshold offers, e.g., self-help
groups and consulting centers, from which the patients can
benefit. Therefore, the likelihood of initiating adequate
aftercare should be reasonable. However, the main aim of
the intervention is to provide the patients with tools that
enable them to continue organizing their aftercare them-
selves. Presumably, in addition to symptom severity, health-
related quality of life and self-efficacy will also be improved
by the case management-based intervention; therefore,
these latter parameters will also be included as secondary
outcome measures. Learning to manage aftercare treatment
successfully themselves might be an experience that
promotes feelings of satisfaction and self-efficacy in the
patients. As an additional secondary outcome, the pro-
portion of patients who managed to begin outpatient
psychotherapy at follow-up will be assessed. It is expected
to be higher in the IG than in the CG due to the support-
ing aftercare intervention. Presumably, the study will have
high external validity because the participants will be con-
secutively recruited from routine care and routine clinical
settings. If the intervention is found to be effective and ac-
cepted by the patients and professionals, an accessible
supplementary treatment approach that can help to over-
come barriers in the clinical pathways will be made avail-
able for patients following inpatient treatment. Treatment
barriers due to the lack of integration of the different care-
giving systems are common problems in the German
health care system [5]. Therefore, aftercare coordination
could also be adapted to the needs of and applied to
patients with other mental disorders and chronic diseases.
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